Px Wire April-June 2015, Vol. 8, No. 2

Px Wire is AVAC’s quarterly update covering the latest in the field of biomedical HIV prevention research, implementation and advocacy. In this issue, you’ll find updates and how WHO is approaching broader guidance on oral PrEP and a closer look at passive immunization.

Our centerspread provides a quick primer on passive immunization with HIV-specific antibodies, long-acting antiretroviral injectables, and preventive vaccines, including a new, informative table reviewing the pipelines in research and development for all three research avenues.

AIDS Vaccine Science for Busy Advocates – Passive Immunization: An important piece of the puzzle

A one-page document describing passive immunization, the transfer of pre-made antibodies, and its potential for HIV prevention.

Neutralizing Antibodies: Research pathways in 2013 and beyond

There are multiple lines of inquiry stemming from the discovery of potent, broadly neutralizing antibodies that have been isolated from HIV-infected individuals. This graphic from AVAC Report 2012 presents two pathways exploring the use of BNAbs as an HIV prevention tool.